Free delivery on orders over £40 Oral weight loss is here UK-registered prescribers, GPhC regulated Free delivery on orders over £40 Oral weight loss is here UK-registered prescribers, GPhC regulated Free delivery on orders over £40 Oral weight loss is here UK-registered prescribers, GPhC regulated

GLP-1 Tablets vs Injections: Which Weight Loss Treatment Is Right for You in 2026?

Date: 07 / Jul / 2026

Everslim Weight Loss Hub

GLP-1 Tablets vs Injections: Which Weight Loss Treatment Is Right for You in 2026?

With the Wegovy pill now MHRA approved, UK patients have a genuine choice between needle-free tablets and weekly injections for the first time. Here is how Mounjaro, Wegovy and the Wegovy pill actually compare.

Quick Answer

GLP-1 tablets and GLP-1 injections use the same class of medicine to support appetite control and weight loss, but they are taken differently. Injections such as Mounjaro and Wegovy are given once a week with a pre-filled pen. The Wegovy pill, MHRA approved on 11 June 2026, is the UK’s first oral GLP-1 tablet, taken once a day on an empty stomach. Neither format is automatically “better.” The right choice depends on your BMI, medical history, comfort with needles, and how you prefer to fit treatment into your routine. Both routes are prescription-only and require a full clinical assessment before any medicine is dispensed. The Wegovy pill is not yet on general sale in the UK; it is expected to launch in late July or early August 2026, with private clinics such as Everslim among the first routes of access.

What Are GLP-1 Tablets and Injections?

GLP-1 receptor agonists are a class of prescription medicines that mimic a natural hormone your gut releases after eating. This hormone signals to the brain that you are full, slows digestion, and helps stabilise blood sugar. In practice, this usually means fewer cravings, smaller portions feeling satisfying, and less snacking between meals.

Until June 2026, every licensed GLP-1 weight loss medicine in the UK was an injection. Wegovy (semaglutide) and Mounjaro (tirzepatide) are both delivered as a weekly injection using a simple pre-filled pen. Mounjaro is a “dual” medicine, acting on both GLP-1 and GIP hormone receptors, which is one reason it has shown greater average weight loss in clinical trials.

The Wegovy pill changes that picture. It contains the same active ingredient as the Wegovy injection, oral semaglutide, but is swallowed once a day rather than injected weekly. It works through the same biological mechanism; the difference is the route into your bloodstream, and the strict food-timing rules that come with taking a peptide medicine by mouth.

A fourth option, Orlistat, works completely differently. It is not a GLP-1 medicine at all, but a capsule that reduces the amount of dietary fat your gut absorbs. It is included here because it remains a legitimate, non-injectable prescription option for people who are not suitable for, or do not want, a GLP-1 treatment.

When Treatment May Be Suitable

Prescription weight loss medication is not automatically appropriate for everyone who wants to lose weight, and no responsible provider should suggest otherwise. In general, GLP-1 treatments (Mounjaro, Wegovy injection and the Wegovy pill) may be considered for adults with:

BMI of 30 or above

Classed as living with obesity, based on the standard adult BMI thresholds used across the NHS.

BMI of 27 to 30

Alongside a weight-related health condition, such as type 2 diabetes, high blood pressure or sleep apnoea.

Orlistat has a slightly lower entry threshold, generally from a BMI of 28. BMI is only a starting point, not a diagnosis. It does not account for muscle mass, ethnicity-specific risk, or overall health, which is why every Everslim order goes through an individual clinical assessment rather than an automatic BMI cut-off. You can check your own BMI using the NHS BMI calculator before booking a consultation.

These treatments are not suitable for everyone. They are not licensed for use in pregnancy or while breastfeeding, and your prescriber will need a full picture of your medical history, current medication, and any personal or family history of medullary thyroid cancer, Multiple Endocrine Neoplasia syndrome type 2, or pancreatitis before approving treatment.

Compare eating options on weight loss medication

Available Treatment Options

Mounjaro (Tirzepatide) Injection

A once-weekly injection acting on both GLP-1 and GIP receptors. In clinical trials, patients on the highest dose lost an average of 22.5% of body weight over 72 weeks. From £139 per month, prescription included, with the final price depending on dose and confirmed at checkout.

View Mounjaro details →

Wegovy (Semaglutide) Injection

A once-weekly GLP-1 injection. In clinical trials, patients lost an average of 17% of body weight over 68 weeks. From £99 per month, prescription included.

View Wegovy details →

Wegovy Pill (Oral Semaglutide)

The UK’s first daily GLP-1 tablet, MHRA approved on 11 June 2026. Taken once a day on an empty stomach, with a gradual titration from 1.5mg up to a 25mg maintenance dose. Check the current product listing for availability and prices.

Orlistat Capsules

A non-GLP-1, non-injectable capsule taken three times daily with meals, reducing fat absorption in the gut. Typically supports 5 to 10% body weight loss over 12 months alongside a reduced-calorie diet. From £39.99 per month, prescription included.

View Orlistat details →

Comparison Table

FeatureMounjaro InjectionWegovy InjectionWegovy PillOrlistat
FormatWeekly injectionWeekly injectionDaily tabletCapsule, 3x daily
MechanismGLP-1 and GIP receptor agonistGLP-1 receptor agonistGLP-1 receptor agonistFat absorption (lipase) inhibitor
Average trial weight lossUp to 22.5% (72 weeks)Around 17% (68 weeks)Comparable to injection at maintenance dose5 to 10% (12 months)
Food timing rulesNoneNoneEmpty stomach, wait 30 minutesTaken with meals
StorageFridge before first useFridge before first useRoom temperatureRoom temperature
Price from£139/month£99/monthTo be confirmed£39.99/month

Prices and availability are correct at the time of writing and are confirmed during checkout. Individual results vary depending on dose, adherence and lifestyle; your prescriber will discuss realistic expectations for your circumstances.

Already on the Wegovy injection?

The MHRA has confirmed that patients using the full 2.4mg weekly Wegovy injection can switch directly to the 25mg daily Wegovy pill without restarting titration from the lowest dose. Read our complete guide to switching from injections to the Wegovy pill for more detail.

Safety and Suitability

Both tablets and injections in the GLP-1 class are prescription-only medicines. That means no reputable provider, including Everslim, will dispense them without a genuine clinical assessment covering your medical history, current medications, BMI, and personal circumstances. This is a legal and clinical safeguard, not a formality.

Tablets bring a different day-to-day discipline than injections. Because oral semaglutide is a peptide, it needs to be taken on an empty stomach after fasting for at least eight hours, swallowed whole with a small sip of water only, with a further 30-minute wait before eating, drinking, or taking other oral medicines. Missing this routine reduces how much of the dose your body actually absorbs. Injections avoid this issue entirely, which suits people who prefer a simpler weekly routine, while some people prefer the tablet specifically to avoid needles.

Neither format is inherently safer than the other; MHRA approval means both routes have met the same regulatory bar for quality, safety and effectiveness. The right choice is a clinical decision made with your prescriber, not a lifestyle preference alone.

Weight loss pen in hand

Side Effects and When to Seek Help

The most commonly reported side effects for both GLP-1 tablets and injections are gastrointestinal: nausea, diarrhoea, constipation and vomiting. These tend to be most noticeable in the first weeks of treatment or after a dose increase, and usually settle as your body adjusts. Orlistat’s side effects are different and relate to its mechanism, commonly including oily or loose stools, particularly after high-fat meals.

Seek urgent medical help if you experience:

  • Severe, persistent abdominal pain, especially if it spreads to your back
  • Yellowing of the skin or eyes, or dark urine
  • Signs of a severe allergic reaction, such as swelling of the face or throat, or difficulty breathing
  • Signs of severe dehydration from persistent vomiting or diarrhoea

If any of these occur, contact NHS 111, your GP, or call 999 in an emergency. Do not wait for your next Everslim check-in.

Suspected side effects from any medicine can also be reported through the MHRA’s Yellow Card scheme, which helps regulators monitor medicine safety across the UK.

Buying Safely Online in the UK

Interest in GLP-1 tablets and injections has, unfortunately, also fuelled a market in counterfeit pens and unregulated tablets sold without any prescription or clinical oversight. Before buying weight loss medication online, check that the provider:

  • Requires a genuine online consultation reviewed by a UK-registered prescriber, not just a payment form
  • Is dispensed by a pharmacy registered with the General Pharmaceutical Council (GPhC)
  • Publishes clear, upfront pricing with no hidden fees
  • Gives you ongoing access to a pharmacist or prescriber, not just a one-off transaction

For more detail on spotting red flags, see our guide on how to buy weight loss medication safely online in the UK.

Alternatively, use our handy calculator to assess how much weight you could lose on weight loss medication:


Why Choose Everslim

GPhC Registered

Dispensed by Everest Pharmacy Hub, a GPhC and NHS-registered pharmacy operating since 2008.

Clinician-Led

Every order is reviewed by a UK-registered independent prescriber before dispensing.

Transparent Pricing

No hidden fees, and you are only charged if your prescription is approved.

Everslim is the dedicated weight management service from Everest Pharmacy, a pharmacy group with over 40 branches across the UK. Whether you choose an injection today or want to be first in line for the Wegovy pill, you are supported by the same clinical team from consultation through to ongoing check-ins, not left to manage a prescription-only medicine alone.

Start Your Free Consultation

FAQs

Click on each question to reveal the answers our clients are looking for:

Is the Wegovy pill as effective as the Wegovy injection?

The Wegovy pill contains the same active ingredient, semaglutide, and works through the same mechanism as the injection. The MHRA has confirmed patients on the full 2.4mg weekly injection dose can switch directly to the 25mg daily tablet, reflecting a comparable effect at full maintenance doses. Individual results still vary, and taking the tablet correctly on an empty stomach matters for absorption.

Do GLP-1 tablets have different side effects to injections?

The side effect profile is broadly similar, mainly nausea, diarrhoea, constipation and vomiting, since both formats deliver the same or a similar active ingredient. Because tablets are taken daily rather than weekly, some people notice side effects more consistently at first, though these usually settle with time.

Will GLP-1 tablets be available on the NHS?

Not currently. NHS availability of the Wegovy pill will depend on a future evaluation by NICE. In the meantime, regulated private clinics such as Everslim are expected to be the first route of access for most patients.

Should I wait for the tablet or start an injection now?

This depends on your personal preferences and clinical suitability, and is worth discussing directly with a prescriber. Some patients prefer to start treatment now with an injection, while others who are needle-averse may prefer to wait for the tablet. There is no universally “right” answer, and your prescriber can talk through the trade-offs based on your health profile.

Ready to Find Your Right Fit?

Start a free online consultation and a GPhC-registered prescriber will help you decide between a tablet or an injection, based on your health, not just your preference.

Check Your Eligibility

Medical Disclaimer

This article is for general information only and does not constitute medical advice. It is not a substitute for a consultation with a qualified healthcare professional. Prescription weight loss medicines, including Mounjaro, Wegovy, the Wegovy pill and Orlistat, are not suitable for everyone and require a full clinical assessment before use. Do not start, stop or change any medication based on this article alone. If you have concerns about your health, or experience any of the red flag symptoms described above, seek advice from your GP, pharmacist, NHS 111, or emergency services as appropriate.

Clinically Reviewed

Medically and clinically reviewed by the Superintendent Pharmacist

Muhammad Mian MPharmS IP

Independent Prescribing Pharmacist

GPhC Registration Number: 2066548

Muhammad Mian is our Sales and Commercial Director at Everslim, as well as an experienced Independent Prescribing Pharmacist. With over 20 years in the healthcare sector, he combines deep clinical expertise with strategic insight to help drive safe, effective and personalised weight loss journeys for our patients.

All medical content on this page is reviewed for clinical accuracy, regulatory compliance and alignment with current UK prescribing standards.

Last reviewed: July 2026

Ready to Take the Next Step? Start Your Weight Loss Journey Today!

Take our short 5 minute questionnaire now.